Discover 3,059 paid clinical trials in Cambridge, Massachusetts. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,059
A First-in-human Study of RLY-8161 in Advanced NRAS-Mutant Solid Tumors
for
Advanced NRAS-Mutant Melanoma,
Location: Boston MA, New York NY, Fairfax VA, Grand Rapids MI,
Sponsor: Relay Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07584226
Phase 1, Recruiting
A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
for
Meningioma
Location: Boston MA, Providence RI, New York NY, Fairfax VA,
Sponsor: Exelixis
Sex: All
Age: 18+
Code: NCT07428616
Phase 2, Recruiting
Remote Monitoring and Symptom Management Digital Application
for
Breast Cancer (Locally Advanced or Metastatic), Lymphoma,
Location: Boston MA
Sponsor: Patrick C. Johnson, MD
Sex: All
Age: 18+
Code: NCT07553572
Recruiting
Advanced Imaging to Assess the Effect of Immunosuppression on Progressive Fibrosis
for
Interstitial Lung Disease, Pulmonary Fibrosis
Location: Boston MA
Sponsor: Peter Caravan
Sex: All
Age: 18 - 70+
Code: NCT07572383
Phase 2, Recruiting
PDAC-PATHWAYS: A Digital Informational and Supportive Care App for Patients Initiating Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma
for
PDAC - Pancreatic Ductal Adenocarcinoma
Location: Boston MA
Sponsor: Massachusetts General Hospital
Sex: All
Age: 18+
Code: NCT07047807
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Observational Study of Adults and Adolescents With Erythropoietic Protoporphyria (EPP) and X-linked Porphyria (XLP)
Effects of IL-1 Beta Inhibition on Vascular Inflammation in TET2 Clonal Hematopoiesis
for
Vascular Inflammation, ASCVD, ASCVD Management
Location: Boston MA
Sponsor: Massachusetts General Hospital
Sex: All
Age: 18+
Code: NCT06691217
Phase 2, Recruiting
A Phase 1/2 Study of TRI-611 in ALK-Positive NSCLC
for
ALK-positive NSCLC, ALK-Positive Lung Cancer,
Location: Boston MA, New York NY, Fairfax VA, Pittsburgh PA,
Sponsor: TRIANA Biomedicines, Inc.
Sex: All
Age: 18+
Code: NCT07491497
Phase 1, Phase 2, Recruiting
Mezigdomide and Talquetamab in Relapsed and Refractory Multiple Myeloma
for
Relapsed Refractory Multiple Myeloma (RRMM)
Location: Boston MA
Sponsor: Massachusetts General Hospital
Sex: All
Age: 18+
Code: NCT07032714
Phase 1, Recruiting
Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF)
Location: Boston MA, New Hyde Park NY, The Bronx NY, New York NY,
Sponsor: Medtronic Cardiac Ablation Solutions
Sex: All
Age: 18+
Code: NCT07298473
Recruiting
A Study to Learn More About the Long-Term Safety of Tofersen (Qalsody) in Participants With Superoxide Dismutase 1 (SOD-1) Amyotrophic Lateral Sclerosis (ALS)
for
Amyotrophic Lateral Sclerosis
Location: Boston MA
Sponsor: Biogen
Sex: All
Age: 18+
Code: NCT07259980
Recruiting
Implementing Depression and Adherence Treatment
for
Depression, HIV, Adherence, Treatment, AIDS
Location: Boston MA, Miami FL
Sponsor: University of Miami
Sex: All
Age: 18+
Code: NCT07032363
Recruiting
ELISA in Relapsed/Refractory MM
for
Relapsed Refractory Multiple Myeloma (RRMM),
Location: Boston MA
Sponsor: Massachusetts General Hospital
Sex: All
Age: 18+
Code: NCT06832865
Phase 2, Recruiting
The TEAM Study - Treatment Efficacy for Autism/Attention Using Mixed Amphetamine